Coexpression cluster:C830
From FANTOM5_SSTAR
Full id: C830_Renal_Endothelial_adipose_Mast_ovary_testis_Lymphatic
Phase1 CAGE Peaks
Hg19::chr14:54421190..54421212,- | p5@BMP4 |
Hg19::chr19:50192842..50192863,+ | p2@C19orf76 |
Hg19::chr2:20647026..20647047,+ | p5@RHOB |
Hg19::chr2:20647862..20647881,+ | p4@RHOB |
Hg19::chr2:26700331..26700340,- | p@chr2:26700331..26700340 - |
Hg19::chr2:26700872..26700884,- | p5@OTOF |
Hg19::chr2:26700900..26700918,- | p4@OTOF |
Hg19::chr2:26700923..26700934,- | p9@OTOF |
Hg19::chr2:26700984..26700993,- | p7@OTOF |
Hg19::chr5:150019594..150019618,+ | p@chr5:150019594..150019618 + |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0001525 | angiogenesis | 0.00352018488905965 |
GO:0048514 | blood vessel morphogenesis | 0.00352018488905965 |
GO:0048646 | anatomical structure formation | 0.00352018488905965 |
GO:0001568 | blood vessel development | 0.00352018488905965 |
GO:0001944 | vasculature development | 0.00352018488905965 |
GO:0021904 | dorsoventral neural tube patterning | 0.00365006475921347 |
GO:0045786 | negative regulation of progression through cell cycle | 0.0043799487752665 |
GO:0032331 | negative regulation of chondrocyte differentiation | 0.0043799487752665 |
GO:0021532 | neural tube patterning | 0.0043799487752665 |
GO:0021978 | telencephalon regionalization | 0.0043799487752665 |
GO:0006927 | transformed cell apoptosis | 0.00461020095924032 |
GO:0045662 | negative regulation of myoblast differentiation | 0.00461020095924032 |
GO:0030501 | positive regulation of bone mineralization | 0.00461020095924032 |
GO:0000074 | regulation of progression through cell cycle | 0.00461020095924032 |
GO:0051726 | regulation of cell cycle | 0.00461020095924032 |
GO:0009887 | organ morphogenesis | 0.00461020095924032 |
GO:0032330 | regulation of chondrocyte differentiation | 0.00461020095924032 |
GO:0007500 | mesodermal cell fate determination | 0.00461020095924032 |
GO:0021871 | forebrain regionalization | 0.00461020095924032 |
GO:0045669 | positive regulation of osteoblast differentiation | 0.00547445247884972 |
GO:0008333 | endosome to lysosome transport | 0.00571230398792825 |
GO:0045778 | positive regulation of ossification | 0.00571230398792825 |
GO:0045661 | regulation of myoblast differentiation | 0.00571230398792825 |
GO:0046852 | positive regulation of bone remodeling | 0.00589521710383024 |
GO:0001710 | mesodermal cell fate commitment | 0.00589521710383024 |
GO:0048333 | mesodermal cell differentiation | 0.00589521710383024 |
GO:0051145 | smooth muscle cell differentiation | 0.00625596459095219 |
GO:0045843 | negative regulation of striated muscle development | 0.00625596459095219 |
GO:0002062 | chondrocyte differentiation | 0.00679507183798379 |
GO:0045667 | regulation of osteoblast differentiation | 0.00706276996781126 |
GO:0001658 | ureteric bud branching | 0.00706276996781126 |
GO:0030500 | regulation of bone mineralization | 0.00752578033711717 |
GO:0022402 | cell cycle process | 0.00752578033711717 |
GO:0045766 | positive regulation of angiogenesis | 0.00772704627624871 |
GO:0016202 | regulation of striated muscle development | 0.00813155691880163 |
GO:0007041 | lysosomal transport | 0.00851355894503422 |
GO:0001707 | mesoderm formation | 0.00887487737891711 |
GO:0032501 | multicellular organismal process | 0.00904102041585094 |
GO:0048332 | mesoderm morphogenesis | 0.00904102041585094 |
GO:0001704 | formation of primary germ layer | 0.00904102041585094 |
GO:0030509 | BMP signaling pathway | 0.00904102041585094 |
GO:0001657 | ureteric bud development | 0.00904102041585094 |
GO:0042475 | odontogenesis of dentine-containing teeth | 0.00904102041585094 |
GO:0021915 | neural tube development | 0.00904102041585094 |
GO:0030278 | regulation of ossification | 0.00904102041585094 |
GO:0007281 | germ cell development | 0.00904102041585094 |
GO:0030282 | bone mineralization | 0.00928784922746442 |
GO:0007049 | cell cycle | 0.00928784922746442 |
GO:0046850 | regulation of bone remodeling | 0.0101319072928017 |
GO:0001656 | metanephros development | 0.0101319072928017 |
GO:0042476 | odontogenesis | 0.0101319072928017 |
GO:0001649 | osteoblast differentiation | 0.0101319072928017 |
GO:0007034 | vacuolar transport | 0.0101319072928017 |
GO:0007369 | gastrulation | 0.0101319072928017 |
GO:0045445 | myoblast differentiation | 0.0101872075412325 |
GO:0001934 | positive regulation of protein amino acid phosphorylation | 0.0101872075412325 |
GO:0033240 | positive regulation of amine metabolic process | 0.0101872075412325 |
GO:0045764 | positive regulation of amino acid metabolic process | 0.0101872075412325 |
GO:0048754 | branching morphogenesis of a tube | 0.0102120604434338 |
GO:0009953 | dorsal/ventral pattern formation | 0.0102120604434338 |
GO:0031902 | late endosome membrane | 0.010235289153024 |
GO:0001709 | cell fate determination | 0.010235289153024 |
GO:0009653 | anatomical structure morphogenesis | 0.0109402046955137 |
GO:0001763 | morphogenesis of a branching structure | 0.0109402046955137 |
GO:0030218 | erythrocyte differentiation | 0.0111081884375619 |
GO:0043010 | camera-type eye development | 0.0112710622458616 |
GO:0051216 | cartilage development | 0.0115459537040865 |
GO:0001822 | kidney development | 0.0115459537040865 |
GO:0006944 | membrane fusion | 0.0115459537040865 |
GO:0048523 | negative regulation of cellular process | 0.0115459537040865 |
GO:0048513 | organ development | 0.0115459537040865 |
GO:0045765 | regulation of angiogenesis | 0.0115459537040865 |
GO:0001655 | urogenital system development | 0.0116809668371001 |
GO:0016197 | endosome transport | 0.0116809668371001 |
GO:0048519 | negative regulation of biological process | 0.0116809668371001 |
GO:0048741 | skeletal muscle fiber development | 0.0116809668371001 |
GO:0030324 | lung development | 0.0116809668371001 |
GO:0048747 | muscle fiber development | 0.0116809668371001 |
GO:0030323 | respiratory tube development | 0.0116809668371001 |
GO:0007498 | mesoderm development | 0.0116809668371001 |
GO:0048468 | cell development | 0.0116809668371001 |
GO:0001932 | regulation of protein amino acid phosphorylation | 0.0116809668371001 |
GO:0030900 | forebrain development | 0.0116809668371001 |
GO:0033238 | regulation of amine metabolic process | 0.0116809668371001 |
GO:0042692 | muscle cell differentiation | 0.0116809668371001 |
GO:0006521 | regulation of amino acid metabolic process | 0.0116809668371001 |
GO:0045597 | positive regulation of cell differentiation | 0.0116809668371001 |
GO:0001654 | eye development | 0.0116809668371001 |
GO:0005770 | late endosome | 0.0125311986003383 |
GO:0042325 | regulation of phosphorylation | 0.01554474559342 |
GO:0045596 | negative regulation of cell differentiation | 0.0156136818634785 |
GO:0007519 | skeletal muscle development | 0.0158747785825665 |
GO:0051094 | positive regulation of developmental process | 0.0158747785825665 |
GO:0051174 | regulation of phosphorus metabolic process | 0.0158747785825665 |
GO:0019220 | regulation of phosphate metabolic process | 0.0158747785825665 |
GO:0045165 | cell fate commitment | 0.0161638094001479 |
GO:0048729 | tissue morphogenesis | 0.0162220066069993 |
GO:0048731 | system development | 0.0164026782168303 |
GO:0008201 | heparin binding | 0.0164956866080014 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 0.0164956866080014 |
GO:0030099 | myeloid cell differentiation | 0.0164956866080014 |
GO:0051093 | negative regulation of developmental process | 0.0164956866080014 |
GO:0035239 | tube morphogenesis | 0.0174754790541053 |
GO:0007423 | sensory organ development | 0.0174754790541053 |
GO:0044440 | endosomal part | 0.0174754790541053 |
GO:0010008 | endosome membrane | 0.0174754790541053 |
GO:0003002 | regionalization | 0.0174754790541053 |
GO:0014706 | striated muscle development | 0.0174754790541053 |
GO:0001503 | ossification | 0.0174754790541053 |
GO:0031214 | biomineral formation | 0.0174754790541053 |
GO:0048869 | cellular developmental process | 0.0180416102903668 |
GO:0030154 | cell differentiation | 0.0180416102903668 |
GO:0007507 | heart development | 0.0180416102903668 |
GO:0009792 | embryonic development ending in birth or egg hatching | 0.0180416102903668 |
GO:0043009 | chordate embryonic development | 0.0180416102903668 |
GO:0046849 | bone remodeling | 0.0180738211415503 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0194280340625341 |
GO:0048771 | tissue remodeling | 0.0194280340625341 |
GO:0005539 | glycosaminoglycan binding | 0.0201791700177027 |
GO:0048856 | anatomical structure development | 0.020737575069496 |
GO:0030247 | polysaccharide binding | 0.0209244188058977 |
GO:0035295 | tube development | 0.0209311946862125 |
GO:0007389 | pattern specification process | 0.0219985960043331 |
GO:0001871 | pattern binding | 0.0223471439314306 |
GO:0050954 | sensory perception of mechanical stimulus | 0.0228549025510702 |
GO:0007605 | sensory perception of sound | 0.0228549025510702 |
GO:0007420 | brain development | 0.0238724756048115 |
GO:0045595 | regulation of cell differentiation | 0.0245343689107644 |
GO:0007275 | multicellular organismal development | 0.0252121697359094 |
GO:0030097 | hemopoiesis | 0.0269952425986517 |
GO:0007517 | muscle development | 0.0285576995570027 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.0285576995570027 |
GO:0002520 | immune system development | 0.0298095579949197 |
GO:0007266 | Rho protein signal transduction | 0.0305570901556772 |
GO:0005768 | endosome | 0.0311328188244837 |
GO:0001501 | skeletal development | 0.0334500930167917 |
GO:0007417 | central nervous system development | 0.0369267618751606 |
GO:0009790 | embryonic development | 0.0369267618751606 |
GO:0050793 | regulation of developmental process | 0.0369267618751606 |
GO:0008083 | growth factor activity | 0.0392842670450358 |
GO:0007276 | gamete generation | 0.0406883426001273 |
GO:0003924 | GTPase activity | 0.0419198021015244 |
GO:0051239 | regulation of multicellular organismal process | 0.0420786967399136 |
GO:0016044 | membrane organization and biogenesis | 0.0428336082681813 |
GO:0016043 | cellular component organization and biogenesis | 0.0446058764501163 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 0.0446058764501163 |
GO:0009888 | tissue development | 0.0450341605435387 |
GO:0005125 | cytokine activity | 0.0452741436959324 |
GO:0032502 | developmental process | 0.0452741436959324 |
GO:0019953 | sexual reproduction | 0.045567020297071 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
endothelial cell | 3.82e-14 | 36 |
lymphangioblast | 7.18e-14 | 6 |
endothelial cell of lymphatic vessel | 7.18e-14 | 6 |
vascular lymphangioblast | 7.18e-14 | 6 |
endothelial cell of vascular tree | 7.86e-14 | 24 |
meso-epithelial cell | 1.28e-10 | 45 |
lining cell | 1.68e-07 | 58 |
barrier cell | 1.68e-07 | 58 |
Ontology term | p-value | n |
---|---|---|
adult organism | 1.51e-23 | 114 |
lymphatic vessel | 2.75e-10 | 8 |
lymph vasculature | 2.75e-10 | 8 |
lymphatic part of lymphoid system | 2.75e-10 | 8 |
anatomical cluster | 2.25e-08 | 373 |
anatomical conduit | 2.36e-08 | 240 |
lymphoid system | 3.91e-08 | 10 |
brainstem | 6.84e-08 | 6 |
throat | 2.53e-07 | 2 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.456919 |
MA0004.1 | 0.380329 |
MA0006.1 | 0.665232 |
MA0007.1 | 1.69684 |
MA0009.1 | 0.828613 |
MA0014.1 | 0.15363 |
MA0017.1 | 0.270554 |
MA0019.1 | 0.520264 |
MA0024.1 | 0.725404 |
MA0025.1 | 0.960689 |
MA0027.1 | 2.43535 |
MA0028.1 | 0.25013 |
MA0029.1 | 0.744375 |
MA0030.1 | 0.733118 |
MA0031.1 | 0.669876 |
MA0038.1 | 0.477043 |
MA0040.1 | 0.750125 |
MA0041.1 | 0.397617 |
MA0042.1 | 0.367902 |
MA0043.1 | 0.828925 |
MA0046.1 | 0.817858 |
MA0048.1 | 0.220931 |
MA0050.1 | 0.368721 |
MA0051.1 | 0.473017 |
MA0052.1 | 0.753928 |
MA0055.1 | 0.577037 |
MA0056.1 | 0 |
MA0057.1 | 1.22133 |
MA0058.1 | 0.796055 |
MA0059.1 | 0.291897 |
MA0060.1 | 0.430116 |
MA0061.1 | 0.118318 |
MA0063.1 | 0 |
MA0066.1 | 0.477449 |
MA0067.1 | 1.1435 |
MA0068.1 | 0.0911063 |
MA0069.1 | 0.814052 |
MA0070.1 | 0.803003 |
MA0071.1 | 1.12112 |
MA0072.1 | 0.798564 |
MA0073.1 | 0.311193 |
MA0074.1 | 0.4723 |
MA0076.1 | 0.307383 |
MA0077.1 | 0.790956 |
MA0078.1 | 0.568317 |
MA0081.1 | 0.292043 |
MA0083.1 | 0.836033 |
MA0084.1 | 1.32998 |
MA0087.1 | 0.79615 |
MA0088.1 | 0.300184 |
MA0089.1 | 0 |
MA0090.1 | 0.320494 |
MA0091.1 | 0.382762 |
MA0092.1 | 0.347826 |
MA0093.1 | 0.671378 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 1.2287 |
MA0101.1 | 0.241637 |
MA0103.1 | 0.228129 |
MA0105.1 | 0.0508589 |
MA0106.1 | 0.516528 |
MA0107.1 | 0.179177 |
MA0108.2 | 0.666881 |
MA0109.1 | 0 |
MA0111.1 | 0.33284 |
MA0113.1 | 1.31824 |
MA0114.1 | 0.174997 |
MA0115.1 | 1.06753 |
MA0116.1 | 2.31128 |
MA0117.1 | 0.865782 |
MA0119.1 | 0.760742 |
MA0122.1 | 0.891407 |
MA0124.1 | 1.0263 |
MA0125.1 | 0.942948 |
MA0130.1 | 0 |
MA0131.1 | 0.585907 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.858623 |
MA0136.1 | 0.483775 |
MA0139.1 | 0.716757 |
MA0140.1 | 0.437738 |
MA0141.1 | 0.789887 |
MA0142.1 | 0.638837 |
MA0143.1 | 0.532484 |
MA0144.1 | 0.163394 |
MA0145.1 | 0.945459 |
MA0146.1 | 0.0551603 |
MA0147.1 | 0.543675 |
MA0148.1 | 0.403564 |
MA0149.1 | 0.428597 |
MA0062.2 | 0.114378 |
MA0035.2 | 0.437071 |
MA0039.2 | 0.360905 |
MA0138.2 | 0.569505 |
MA0002.2 | 0.407187 |
MA0137.2 | 0.255808 |
MA0104.2 | 0.845907 |
MA0047.2 | 0.504873 |
MA0112.2 | 3.406 |
MA0065.2 | 0.963081 |
MA0150.1 | 0.315136 |
MA0151.1 | 0 |
MA0152.1 | 0.443956 |
MA0153.1 | 0.926242 |
MA0154.1 | 0.729959 |
MA0155.1 | 3.30773 |
MA0156.1 | 0.257809 |
MA0157.1 | 0.612166 |
MA0158.1 | 0 |
MA0159.1 | 0.544949 |
MA0160.1 | 1.07255 |
MA0161.1 | 0 |
MA0162.1 | 0.108522 |
MA0163.1 | 0.484115 |
MA0164.1 | 0.544294 |
MA0080.2 | 0.238846 |
MA0018.2 | 3.27184 |
MA0099.2 | 0.444294 |
MA0079.2 | 0.48867 |
MA0102.2 | 1.36707 |
MA0258.1 | 4.43327 |
MA0259.1 | 0.191914 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
NR3C1#2908 | 4 | 5.98920933246922 | 0.00301039080914885 | 0.015987907740488 |
TFAP2A#7020 | 5 | 8.25931718652248 | 0.000158182952393598 | 0.00199402164937054 |
TFAP2C#7022 | 5 | 5.40461430493011 | 0.00114527086823733 | 0.007834093804548 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.